In my view, the next big announcement shall be a big pharma partner for COVID-19. The last 4C put the discussions ongoing for at least a month. During the last conf call, the CFO refused to get drawn into a discussion or answer the analyst question on funds allocated for manufacturing in next quarters. Maybe the last fresh equity funds raise put the company in a better negotiation position, but won’t actually be needed for manufacturing if there is a big pharmaceutical partnership....
Here is an excerpt from MESOBLAST’s last 4C: “Mesoblast is in active discussions with US and other government authorities as well as potential pharmaceutical partners with respect to its plans for ramp-up of commercial manufacturing for remestemcel-L in COVID-19 ARDS.”
http://investorsmedia.mesoblast.com/static-files/04851ade-aca5-492c-9784-45ae8c772f04
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease, page-144
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.267B |
Open | High | Low | Value | Volume |
$1.13 | $1.13 | $1.06 | $12.24M | 11.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32118 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 21178 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32118 | 1.105 |
1 | 5000 | 1.100 |
3 | 15300 | 1.090 |
4 | 57493 | 1.085 |
3 | 29560 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.115 | 21178 | 2 |
1.120 | 10880 | 3 |
1.125 | 63186 | 5 |
1.130 | 120135 | 5 |
1.135 | 29000 | 2 |
Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.10 |
  |
Change
0.000 ( 2.07 %) |
|||
Open | High | Low | Volume | ||
$1.12 | $1.12 | $1.06 | 1826006 | ||
Last updated 15.59pm 31/05/2024 ? |
Featured News
MSB (ASX) Chart |